Company Filing History:
Years Active: 2011
Title: The Innovations of Matthew Stokes
Introduction
Matthew Stokes is an accomplished inventor based in Beverly, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of cancer research. His work has led to the development of novel diagnostic and therapeutic tools that have the potential to improve patient outcomes.
Latest Patents
Matthew Stokes holds a patent for his invention titled "Tyrosine phosphorylation sites." This patent discloses 482 novel phosphorylation sites identified in carcinoma and/or leukemia. The invention includes peptides, such as AQUA peptides, that comprise a phosphorylation site, as well as antibodies that specifically bind to these novel phosphorylation sites. The diagnostic and therapeutic uses of these innovations are significant in advancing cancer treatment.
Career Highlights
Matthew Stokes is currently employed at Cell Signaling Technology, Inc., where he continues to push the boundaries of scientific research. His work at this company has been instrumental in developing tools that aid researchers in understanding cellular signaling pathways.
Collaborations
Some of his notable coworkers include Peter Hornbeck and Ailan Guo. Their collaborative efforts contribute to the innovative environment at Cell Signaling Technology, Inc.
Conclusion
Matthew Stokes is a prominent figure in the field of biotechnology, with a focus on cancer research and innovative solutions. His contributions through patents and collaborations highlight the importance of scientific advancements in improving healthcare.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.